key: cord-0683089-txuthqgo
authors: Davidson, Andrew D.; Williamson, Maia Kavanagh; Lewis, Sebastian; Shoemark, Deborah; Carroll, Miles W.; Heesom, Kate; Zambon, Maria; Ellis, Joanna; Lewis, Phillip A.; Hiscox, Julian A.; Matthews, David A.
title: Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site
date: 2020-03-24
journal: bioRxiv
DOI: 10.1101/2020.03.22.002204
sha: 6ad39be296a7e5c6c7f03a5f41348fc3339fdaf1
doc_id: 683089
cord_uid: txuthqgo

Direct RNA sequencing using an Oxford Nanopore MinION characterised the transcriptome of SARS-CoV-2 grown in Vero E6 cells. This cell line is being widely used to propagate the novel coronavirus. The viral transcriptome was analysed using a recently developed ORF-centric pipeline. This revealed the pattern of viral transcripts, (i.e. subgenomic mRNAs), generally fitted the predicted replication and transcription model for coronaviruses. A 24 nt in-frame deletion was detected in subgenomic mRNAs encoding the spike (S) glycoprotein. This feature was identified in over half of the mapped transcripts and was predicted to remove a proposed furin cleavage site from the S glycoprotein. This motif directs cleavage of the S glycoprotein into functional subunits during virus entry or exit. Cleavage of the S glycoprotein can be a barrier to zoonotic coronavirus transmission and affect viral pathogenicity. Allied to this transcriptome analysis, tandem mass spectrometry was used to identify over 500 viral peptides and 44 phosphopeptides, covering almost all of the proteins predicted to be encoded by the SARS-CoV-2 genome, including peptides unique to the deleted variant of the S glycoprotein. Detection of an apparently viable deletion in the furin cleavage site of the S glycoprotein reinforces the point that this and other regions of SARS-CoV-2 proteins may readily mutate. This is of clear significance given the interest in the S glycoprotein as a potential vaccine target and the observation that the furin cleavage site likely contributes strongly to the pathogenesis and zoonosis of this virus. The viral genome sequence should be carefully monitored during the growth of viral stocks for research, animal challenge models and, potentially, in clinical samples. Such variations may result in different levels of virulence, morbidity and mortality.

Since the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) as a human pathogen at the end of 2019, the virus has spread globally, causing > 312 000 confirmed cases of COVID-19 and 13,400 deaths as of the 22 nd March, 2020 1 . Although vaccines are under rapid development to prevent SARS-CoV-2 infection, little is known of either the immune correlates of protection or the ability of the virus to avoid the host immune response through mutation and recombination 2 .

The genome sequence was rapidly determined and revealed that SARS-CoV-2 is most closely related to bat coronavirus RaTG13 and clusters with SARS-CoV, that emerged in 2002, in the genus Betacoronavirus of the family Coronaviridae 3, 4 . Based on homology to other known coronaviruses 3, 4 , the genome sequence was used for viral transcript prediction and the annotation of ORFs. Coronaviruses use a complex strategy to express their genetic information 5 , and transcription is initiated from defined (and sometimes cryptic) transcription associated sequences 6 . Similar, to other coronaviruses, the SARS-CoV-2 29.9 kB RNA genome contains two large ORFs, ORF1a and ORF1ab, predicted to be initially translated into the polyproteins, pp1a, and pp1ab that arises by ribosomal frameshifting ( Figure 1A ). The polyproteins are post-translationally processed by viral encoded proteases to produce 16 proteins that are conserved between coronaviruses and proposed to function in the synthesis of viral RNA and immune evasion 7 . During viral genome replication a set of "nested" subgenomic mRNAs are produced that are predicted to encode the structural proteins spike (S), envelope (E), membrane (M) and nucleocapsid (N) and at least nine small accessory proteins, some of which are unique to SARS-CoV-2 3, 4 . The subgenomic mRNAs have a common 5' leader sequence and are 3' co-terminal with a polyA tail.

This feature is likely to be added by viral encoded proteins in the cytoplasm of an infected cell.

Recently, the SARS-CoV-2 transcriptome has been examined using direct RNAseq (dRNAseq) 8, 9 . Furthermore, a recent proteomic study showed that a number of the predicted viral proteins are produced in infected cells, but not all of the predicted viral proteins were detected 10 . We pioneered the use of combining transcriptomics and proteomics to study viral infections in vitro and in vivo, initially using the well characterised respiratory virus, adenovirus but also respiratory syncytial virus and highly pathogenic zoonotic viruses such as Hendra virus [11] [12] [13] . More recently we have focussed on the latest technologies to study the transcriptome of viruses, including direct RNA sequencing on nanopore devices using long read length sequencing. In particular, we developed a novel ORF-centric pipeline to analyse the very large amounts of transcriptomic data generated by this technique 14 . This pipeline was first used on data generated from adenovirus infected cells. The approach rapidly reproduced transcript maps that correlated highly with the previously described transcriptome maps of adenovirus which have been carefully curated over several decades.

The SARS-CoV-2 subgenomic mRNAs encoding the structural proteins and their expression profiles are of particular interest as the encoded proteins are likely targets of a protective immune response. The coronavirus S glycoprotein is present as a homotrimer, protruding from the surface of the virion. It is a key determinant of viral tropism and the major antigenic target 15, 16 . The S glycoprotein is a class I fusion protein comprised of two domains, S1 and S2, responsible for receptor binding and the fusion of viral and cellular membranes respectively 17, 18 . The coronavirus S glycoprotein of coronaviruses is primed for cell entry by host cell proteases that cleave the protein at one or more positions. Cleavage of a "S1/S2" site at the boundary of the S1 and S2 domains occurs for some coronaviruses whilst cleavage at a "S2" site is common to all coronaviruses and results in activation of a highly conserved fusion peptide immediately downstream of the S2 site [19] [20] [21] . Although the SARS-CoV-2 S glycoprotein shares 97% identity with that of bat coronavirus RaTG13 22 , an important difference is the presence of a four amino acid insertion (681PRRA684) at the S1/S2 cleavage site that introduces a potential furin-like cleavage site 23, 24 . The furin cleavage site is also not found in other "lineage B" betacoronaviruses including SARS-CoV, but has been detected in betacoronaviruses in other lineages, suggesting that this region has arisen during natural evolution 25 .

Here we used a combined transcriptomics and proteomics approach to produce a correlated transcriptome and proteome map of SARS-CoV-2 in the African Green monkey kidney cell line Vero E6. This cell line is routinely used globally to propagate viruses from clinical samples as well as to generate stocks of virus for academic research, drug susceptibility testing and vaccine challenge studies. There was a close correlation between predicted viral transcriptome and proteome maps as well as novel transcripts that encoded for proteins detected by tandem mass spectrometry. Finally, evidence was gathered for an in-frame deletion inside the S glycoprotein that removed the proposed furin cleavage site.

Complete characterisation of a novel and dangerous pathogen at a molecular level is highly desirable. Although analysis of the SARS-CoV-2 genome enables high confidence prediction of potential transcripts and ORFS, there is a pressing need to have the predictions confirmed and novel transcripts identified and assessed for biological significance and role in virulence and pathogenesis. At the same time, independent confirmation that viral transcripts were expressed was achieved by tandem mass spectrometry-based proteomics. This provided direct observation of the whole range of viral proteins and helped resolve ambiguities in the transcriptomic data.

Finally, identification of phosphorylation sites provided an invaluable list of therapeutic targets based on kinase inhibitors. Using proteomics informed by transcriptomics (PIT) 11 on duplicate infected cells offered a rapid and high resolution approach to these key molecular virology questions.

Long read length sequencing using an Oxford Nanopore MinION on polyA+ RNA from cells infected with SARS-CoV-2 was used to characterise viral RNA species. This technique has recently been used to study herpes viruses, coronaviruses and adenovirus transcriptomes 14, 26, 27 . In total, 1,588,330 sequences were base called and passed QC, of those 527,401 were mapped to the BetaCoV/England/02/2020 genome using minimap2 (Figure 1b ). In addition, an average polyA tail length for each transcript was generated using nanopolish and this information was added to the analysis pipeline. A strict cut off of a 20 nt minimum polyA length was employed and 386,903 transcripts passed this test. Accurately determining the 5' end of direct RNAseq transcripts has been shown to be problematic 14, 27, 28 . The accepted model for coronavirus transcription (Figure 1a) proposes that all viral mRNAs have a common 5' end 29 and the analysis herein was further restricted to those transcripts that met this criterion which reduced the total number of identified full length subgenomic mRNA molecules to 72,124. Figure 1c illustrates a transcription map of those transcripts that start at the expected location and have a known ORF as the 5' most ORF. Transcripts that could express all of the predicted ORFs were present, including for the newly predicted ORF10 30 . However, only one transcript was detected and as previously suggested 8,9 the status of this as a genuine transcript needs careful further investigation. Moreover, non-canonical TRS joining events were detected leading to, for example, apparently bone fide subgenomic transcripts coding for ORF7b. this was also recently reported by Kim et al. 8 . The distribution of transcripts with a 5' UTR consistent with the model of coronavirus mRNA expression that would also code for a predicted protein are shown in Table 1 . Also reported are the average polyA tail lengths of each transcript group. These appeared to be shorter than most human eukaryotic transcripts but is consistent with recently reported findings for SARS-CoV- 

Manual inspection of the transcripts aligned to the virus genome revealed a large number of reads that aligned to the gene encoding the S glycoprotein with a 24 nt deletion. This was predicted to result in a deletion of 9 aa, encompassing the proposed furin-like cleavage site (Figure 2a) with the replacement of a single isoleucine residue.

Indeed the analysis revealed that there were a large number of transcripts that had both a polyA tail > 20 nt and a start at the proposed transcription start location, more than the full length S-glycoprotein (Table 1) . To confirm this finding and examine if the deletion was present in the original stock samples at the PHE reference laboratory, the region was PCR amplified from the virus passaged at Bristol or from the original stock. These amplified fragments were sequenced using the Sanger method. This revealed that the Bristol stock was indeed a mixture of genomes but the original stock was solely wild type sequence. Subsequent examination of a very high quality dataset reported recently by Kim et al. 8 did not detect any evidence of similar significant deletions in the S glycoprotein in their data. However, their dataset contained a spontaneous deletion within the region of the genome coding for the E protein resulting in a 9aa in-frame deletion in almost two thirds of the mapped transcripts (Supplementary Figure 1) .

Tandem mass spectrometry was utilised to detect as many viral peptides and phosphopeptides as possible (Supplementary dataset 5). Table 2 illustrates the numbers of peptides found for each of the predicted ORFs. Notably, whilst most of the ORFs detected were also confirmed in the recent report by Bojkova et al. 10 , there were some differences. Whilst we could not detect peptides from ORF9b as described by Bojkova et al., peptides corresponding to the ORF9a protein were identified. This leaves only E, ORF7b and ORF10 to be detected by mass spectrometry. In addition, peptides unique to proteolytically processed components of the viral replicase polyprotein pp1ab; namely nsp4, nsp9, nsp12, nsp13, nsp14 and nsp15 were identified indicating that these important processing steps occurred as predicted (Table 3) .

Initially no unique peptides corresponding to the novel deleted version of the Sglycoprotein were detected by tandem mass spectrometry. However, a typical tryptic digest protocol would generate very large potentially undetectable peptides.

Accordingly, samples were digested using chymotrypsin and the analysis repeated revealing a single peptide corresponding to the deleted version of the S-glycoprotein, but only when using a 5% false discovery threshold. However, this provided sufficient information to enable a targeted search. This identified nine Peptide Spectral Match's (PSMs) with high confidence (i.e. FDR 1%) that corroborated the expression of the deleted spike protein (Supplementary dataset 6).

Transcriptomics and proteomics can be combined to provide unbiased insight into the proteome of viruses and higher eukaryotes 11, 12, 31 . The ORF centric pipeline was used to generate a list of possible ORFs which could be made by translating the first ORF present on every transcript sequenced. As before 14 , to overcome the inherent error prone nature of nanopore sequencing, the transcript was mapped to the viral genome and used the mapping information to create pseudo-transcripts based on the sequence of the viral genome.

Using this list of predicted proteins revealed a large number of novel peptides arising which could not be explained by the standard list of predicted viral proteins. In the majority of cases they appeared to be transcripts with rare and unusual structures likely resulting from rare rearrangements of the viral genome or potentially during subgenomic mRNA synthesis. However, in some cases a large number of similar transcripts were supported by direct peptide evidence that these rearrangements are indeed translated. In particular multiple versions of the N protein with distinct small internal deletions were detected for which 20 transcripts that could encode for these proteins were also identified (Supplementary dataset 7). A schematic of such a deletion in the N protein is shown, indicating the peptide that was identified by tandem mass spectrometry to support the observed transcripts ( Figure 2c ).

Allied to an analysis of viral peptides, the phosphorylation status of viral proteins was investigated as this could reveal potential targets for licenced kinase inhibitors.

Phosphopeptides corresponding to locations on the N, M, ORF 3a, nsp3, nsp9, nsp12 and S-glycoprotein were detected ( Table 4 ). The presence of phosphorylation sites on the S glycoprotein has not been previously noted and may be of significance in terms of vaccines based on this protein, the location of these sites is illustrated (Figure 3 ).

The location of the phosphorlaytion sites on the proteins listed is illustrated in Figure   4 and additional models of the phosphorylation sites on the N-terminal RNA binding domain of the N protein are shown in Figure 5 .

This integrated analysis of the SARS-CoV-2 transcriptome and proteome revealed significant findings, in particular, the identification of an eight aa deletion in the SARS-CoV-2 S glycoprotein that potentially effects protein cleavage, cell tropism and infectivity. The coronavirus S glycoprotein is made as a larger precursor that must be primed by cleavage using host cell proteases to enable subsequent viral entry. For different coronaviruses, cleavage can occur at one or more sites (termed the S1/S2 and S2´ sites) depending on the amino acid consensus sequences present at each site and has major repercussions on host cell tropism and pathogenesis 19 . The SARS-CoV S glycoprotein has a single arginine residue at the S1/S2 site (Figure 2b ), that facilitates cleavage by a number of proteases including trypsin, cathepsin L and TMPRSS11D 32-34 and a consensus sequence for trypsin and/or elastin cleavage at the S2´ site 35, 36 . By comparison, SARS-CoV-2 has a four amino acid insertion (680SPRR683) in the S glycoprotein that results in the generation of a furin-like cleavage site (682RRAR685) at the S1/S2 boundary that is not present in other lineage B betacoronaviruses, including SARS-CoV and the highly related bat coronavirus RaTG13 23 . Moreover, analysis of a cryo-EM structure of the S glycoprotein showed that the SPRR insertion creates a disordered solvent exposed loop 24 that protrudes from the trimer surface (Figure 3a ). It has been proposed that this region is more available to host cell proteases for processing 24 . The presence of a furin-like cleavage site at the S1/S2 boundary results in cleavage of the SARS-CoV-2 S glycoprotein before viral exit from the cell, whereas the S glycoprotein of coronaviruses such as SARS-CoV, lacking a S1/S2 furin cleavage site, exit the cells with the S glycoprotein largely uncleaved, necessitating cleavage prior to or during cell entry 20, 37, 38 .

The SARS-CoV-2 S glycoprotein deletion identified in this study removes the furin cleavage site, but also Arg685 (corresponding to SARS-CoV Arg667) required for cleavage of the SARS-CoV S glycoprotein. However the sequence 694AY/T696 (numbering of undeleted S glycoprotein, cleavage shown by "/"; Figure 2b ) is still retained and has been identified as a second potential S1/S2 protease cleavage site for SARS-CoV downstream of the basic Arg667 residue 23 suggesting that either the deleted SARS-CoV-2 S glycoprotein could be cleaved at this site or only use the S2´ site for cleavage. Recently pseudoviruses expressing the SARS-CoV-2 S-glycoprotein and the corresponding S glycoprotein with the furin cleavage site removed at the S1/S2 boundary (residues 680SPRR683 removed) were made and their ability to mediate entry to Vero E6 and BHK-21 cells expressing hACE2 compared 33 In addition to the S glycoprotein deletion we were also able to find an additional significant deletion, in high quality data recently deposited by Kim et al. 8 

Extraction and sequencing was done as previously described 14 . Briefly, total RNA was extracted using TRIzol™ reagent (#15596026, Ambion) and the RNA extracted as per the manufacturer's recommendations but with 3 x 70% ethanol washes. After resuspension in RNAse-free water the RNA was polyA enriched and sequenced immediately using SQK-RNA002 kits and MIN106D R9 version flow cells (Oxford Nanopore Technologies).

To cope with the very wide range of transcripts, and to enable grouping of transcripts into classes, our previously described ORF centric data analysis pipeline was utilised 14 . The transcripts were mapped to the viral genome with minimap2 and the mapping data was used to identify transcription regulatory sequences (TRS), the sites where the transcript meets the poly A tail at the end of the genome and junction sites which the software refers to as splice acceptor/donor sites as it was originally used to describe spliced adenovirus transcripts. This script produces tables indicating where on the genome and how often in the data each junction occurs. Subsequently, nearby events are grouped together for simplicity of analysis. Once this is complete, the software then assigns each transcript to a "transcript group" depending on its pattern of TRS, junction sites and poly A locations and counts how many transcripts belong to each transcript group. Nanopolish 50 was used to determine the polyA length of each sequenced transcript and subsequently the average polyA length was calculated for each transcript group.

A second in-house script determined which known features are present in each transcript group and generated pseudo transcripts based on the viral genome sequence to remove nanopore sequencing errors. The script examined each pseudotranscript to determine what features it has, using a user-specified list of canonical features or ORFs on the viral genome (Supplementary Data 8) . It also produced GFF files that allow the user to visualise the dominant transcript coding for each ORF as well as GFF files describing the whole range of transcripts coding for any given ORF.

In addition, an analysis counting the final number of transcripts belonging to each translated feature was produced. The pipeline generated an ORF-centric view of the viral transcriptome -classifying transcripts according to the viral proteins coded for.

To prepare intracellular SARS-CoV-2 RNA, total cellular RNA containing SARS-CoV-2 RNA was extracted from the Vero E6 cells used for viral stock production using TRIzol™ Reagent (Invitrogen™, ThemoFisher) following the manufacturer's instructions. Viral RNA was extracted from cell culture supernatants using a QIAamp 

Protein lysates were prepared from the Vero E6 cells used for viral stock production. Fusion Lumos mass spectrometer (Thermo Scientific) as above.

The raw data files were processed using Proteome Discoverer software v2. The genome is itself an mRNA which when translated gives rise to polyproteins pp1a and, upon a ribosomal frameshift, pp1ab. These polyproteins are proteolytically processed down to a range of non-structural proteins termed nsp1-16 some of which will form the viral replication-transcription complex (RTC). The RTC then generates subgenomic mRNA which canonically contains a sequence present at the 5' end of the viral genome known as the Transcription Regulating Sequence -Leader (TRS -L) linked by discontinuous transcription to one of several similar sequences downstream of pp1ab. In this manner the remaining ORFS on the viral genome are placed 5' most on the subgenomic mRNA and are subsequently translated. Part b shows the total read depth across the viral genome for all reads, the maximum read depth was 511,129. Part c illustrates the structure of dominant transcript coding for each of the identified ORFS.

Only transcripts that starts inside the leader TRS sequence are considered here. The black rectangles represent mapped nucleotides and the arrowed lines represent regions of the genome that are skipped. To the right is noted the 5' most ORF is that the transcript would code for, in parenthesis we note how many individual transcripts were observed.

Deletions within the viral mRNA in the S glycoprotein and N In (a) is shown the read depth over the region deleted in the S glycoprotein together with information on the sequence in the region and the translation in all three frames. (b) is a clustal alignment of three proteins over this region, wild type SARS-CoV, wild type SARS-CoV-2, the artificially deleted version of the wild type SARS-Cov_2 S glycoprotein as reported in Walls et al. and finally the predicted sequence of the deleted protein described here. Highlighted in yellow is the sequence of the unique peptide generated by chymotrypsin digest of the protein which was identified by tandem mass spectrometry. (c) illustrates a similar examination of a proposed deletion in the N protein predicted by multiple aligned transcripts and subsequently identified in trypsin digested protein samples as indicated by the unique peptide highlighted in yellow.

A space filled model of the wild type SARS-CoV-2 S glycoprotein in a trimeric form using the sequence of a) the native or b) spike deletant virus, in which the aa's 679NSPRRARSV687 have been replaced with Ile. The model was built using a cryo-EM structure (6VSB.pdb) of the S glycoprotein in the prefusion form (25) . Each of the monomers is coloured differently. The loop containing the furin cleavage site (or the shortened loop in the deleted version in b) is indicated in red. The positions of phosphorylation sites identified by mass spectrometry and surface located were mapped on the native structure and shown in yellow in a).

Schematic of the location of phosphorylation sites Proteins M, N, NSP3, NSP9 and S glycoprotein are shown as we have accurate phospho-site data for these proteins. For each location we indicate the aminos acid (S, T or Y) and the amino acid numbering. The S glycoprotein is shown as S1 and S2 for ease of display and to illustrate where the sites would be relative to the major cleavage site on the wild type Gglycoprotein. Tables   Table 1 .

Only transcripts that start to map within the expected leader TRS are considered. For each transcript group the average polyA length is also shown for the dominant transcript that codes for the indicated ORF. Note that around 14% of transcripts do not apparently code for a recognised ORF, noted as "none from list". Table 2 .

For each protein the total number of unique peptides is indicated alongside how many PSMs support the peptides identified. In the case of the viral polyprotein pp1ab, we also list how many peptides uniquely mapped to each nsp region. Table 3 Peptides unique to processed proteins The polyprotein pp1ab is processed into matured smaller proteins nsp1-16 during infection, this table indicates which unique peptides were identified that could only arise as a result of full polyprotein processing. Table 4 Phosphopeptide counts Listed for each protein is the number of distinct phosphor sites identified along with the locations and amino acid modified as well as how many contributing PSMs there are in total. For proteins ORF3a and nsp12 no distinct site could be identified despite a phosphorylated peptide being found, in these cases the peptide sequence is provided. S2, S105, T141, S176, S180, S183, S184 , T391, S78, S79, T76, S206,  T205, S23, T24, T166, S194, 

An interactive web-based dashboard to track COVID-19 in real time

Experimental evidence of recombination in coronavirus infectious bronchitis virus

A new coronavirus associated with human respiratory disease in China

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Coronaviruses post-SARS: update on replication and pathogenesis

Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts

Unique and conserved features of genome and proteome of SARScoronavirus, an early split-off from the coronavirus group 2 lineage

The architecture of SARS-CoV-2 transcriptome. bioRxiv, 2020

Direct RNA sequencing and early evolution of SARS-CoV-2. bioRxiv

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

De novo derivation of proteomes from transcriptomes for transcript and protein identification

Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL-mediated apoptosis

High Resolution Analysis of Respiratory Syncytial Virus Infection In Vivo

Deep splicing plasticity of the human adenovirus type 5 transcriptome drives virus evolution

Structure, Function, and Evolution of Coronavirus Spike Proteins

Structural insights into coronavirus entry

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

Pre-fusion structure of a human coronavirus spike protein

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide

A pneumonia outbreak associated with a new coronavirus of probable bat origin

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

The proximal origin of SARS-CoV-2

Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis

Direct RNA sequencing on nanopore arrays redefines the transcriptional complexity of a viral pathogen

Highly parallel direct RNA sequencing on an array of nanopores

A contemporary view of coronavirus transcription

A new coronavirus associated with human respiratory disease in China

Proteomics informed by transcriptomics for characterising active transposable elements and genome annotation in Aedes aegypti

Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain

Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide

Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2. bioRxiv

Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya

The coronavirus nucleocapsid is a multifunctional protein

Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription

Phosphorylation of the arginine/serine dipeptiderich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization

Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance

Role of phosphorylation clusters in the biology of the coronavirus infectious bronchitis virus nucleocapsid protein

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. bioRxiv

Coronaviruses: an overview of their replication and pathogenesis

Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

Nanopore native RNA sequencing of a human poly(A) transcriptome

The authors would also like to thank Robin Gopal and Monika Patel from the National Infection Service at PHE Collingdale for isolation, propagation and advice on viral